-
FDA approves Boehringer Ingelheim’s high-concentration formulation of interchangeable Humira biosimilar
Cyltezo, the company’s interchangeable biosimilar to Humira, is used to treat multiple chronic inflammatory diseases. -
Alvotech to manufacture Humira biosimilar for Quallent Pharmaceuticals
The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label.